Company Overview of iTherX, Inc.
iTherX, Inc., a clinical stage pharmaceutical company, discovers and develops antiviral therapeutics for hepatitis C. It provides ITX-5061 to evaluate antiviral activity and safety in patients with hepatitis C virus infection. The company was formerly known as Immusol, Inc. and changed its name to iTherX, Inc. in December 2007. iTherX, Inc. was founded in 1992 and is based in San Diego, California.
700 West East Street
San Diego, CA 92101
Founded in 1992
Key Executives for iTherX, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact iTherX, Inc., please visit www.itherx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.